SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (15318)2/19/1998 11:14:00 AM
From: Flagrante Delictu  Read Replies (1) | Respond to of 32384
 
Henry, >>Mutations in the retinoblastoma {Rb} tumor-suppressor protein are implicated in many types of cancer.<< This seems to tie into the work of Ron Evans previously reported by you on chromatin .
Hopefully LGND has filed patents & tied up most or all of this technology. Bernie. P.S. Michael Murphy's hotline expects LGND stock to rally to the high teens/ low twenties upon filing of the Panretin NDA before 3/31/98.